Jump to ContentJump to Main Navigation

Advances in Medical Sciences

The Journal of Medical University of Bialystok

2 Issues per year

IMPACT FACTOR 2012: 0.796
5-year IMPACT FACTOR: 1.094

Access brought to you by:

provisional account

Open Access
VolumeIssuePage

Open Access

Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease

D Lebensztejn1 / M Wojtkowska1 / E Skiba1, / I Werpachowska1 / J Tobolczyk1 / M Kaczmarski1

Department of Pediatrics, Gastroenterology and Allergology, Medical University of Bialystok, Poland1

Department of Radiology, Children Teaching Hospital, Medical University of Białystok, Poland2

Department of Children Oncology and Hematology, Medical University of Bialystok, Poland3

Department of Clinical Immunology, Medical University of Bialystok, Poland4

This content is open access.

Citation Information: Advances in Medical Sciences. Volume 54, Issue 2, Pages 177–182, ISSN (Online) 1898-4002, ISSN (Print) 1896-1126, DOI: 10.2478/v10039-009-0047-y, December 2009

Publication History

Published Online:
2009-12-10

Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease

Purpose: Obesity, insulin resistance and dyslipidemia are the most significant risk factors of non-alcoholic fatty liver disease (NAFLD) but the role of adipokines in patomechanism of this disease is not clear. The aim of the study was to evaluate the serum levels of leptin, adiponectin and resistin in obese children with NAFLD.

Material/Methods: The fasting serum levels of adipokines were determined in 44 consecutive obese children with suspected liver disease and in 24 lean controls. The degree of the ultrasound liver steatosis was graded according to Saverymuttu.

Results: The fatty liver was confirmed in 33 children by ultrasonography (16 of them also showed an increased ALT activity). The serum leptin level was significantly higher and adiponectin level was lower in the obese children with NAFLD when compared to controls. Only adiponectin correlated with homeostasis model assessment of insulin resistance (HOMA-IR). Significant negative correlations were found between the ultrasonographic grades of liver steatosis and adiponectin and resistin levels. Serum adiponectin and resistin levels were lower in children with an advanced liver steatosis (grade 3, n=10) compared to patients with a mild steatosis (grade 1-2, n=23). The ability of serum adiponectin and resistin to differentiate children with an advanced liver steatosis from those with mild steatosis was significant.

Conclusions: These data suggest a role of both adiponectin and resistin in the pathogenesis of NAFLD in obese children and confirm the association between adiponectin and insulin resistance. Adiponectin and resistin may be suitable serum markers in predicting an advanced liver steatosis in children with NAFLD.

Keywords: adiponectin; leptin; resistin; children; NAFLD; obesity

  • Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002 Apr 18;346(16):1221-31.

  • Patton HM, Sirlin C, Behling C, Middleton M, Schwimmer JB, Lavine JE. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr. 2006 Oct;43(4):413-27. [PubMed] [CrossRef]

  • Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005 Jul;129(1):113-21. [CrossRef] [PubMed]

  • Suzuki D, Hashimoto E, Kaneda K, Tokushige K, Shiratori K. Liver failure caused by non-alcoholic steatohepatitis in an obese young male. J Gastroenterol Hepatol. 2005 Feb;20(2):327-9. [CrossRef]

  • Marion AW, Baker AJ, Dhawan A. Fatty liver disease in children. Arch Dis Child. 2004 Jul;89(7):648-52. [PubMed] [CrossRef]

  • Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004 Jun;89(6):2548-56. [PubMed] [CrossRef]

  • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985 Jul;28(7):412-9. [CrossRef] [PubMed]

  • Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed). 1986 Jan 4;292(6512):13-5.

  • Louthan MV, Barve S, McClain CJ, Joshi- Barve S. Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease. J Pediatr. 2005 Dec;147(6):835-8. [CrossRef] [PubMed]

  • Zou CC, Liang L, Hong F, Fu JF, Zhao ZY. Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children. Endocr J. 2005 Oct;52(5):519-24. [CrossRef] [PubMed]

  • Mandato C, Lucariello S, Licenziati MR, Franzese A, Spagnuolo MI, Ficarella R, Pacilio M, Amitrano M, Capuano G, Meli R, Vajro P. Metabolic, hormonal, oxidative, and inflammatory factors in pediatric obesity-related liver disease. J Pediatr. 2005 Jul;147(1):62-6. [PubMed] [CrossRef]

  • Burgert TS, Taksali SE, Dziura J, Goodman TR, Yeckel CW, Papademetris X, Constable RT, Weiss R, Tamborlane WV, Savoye M, Seyal AA, Caprio S. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab. 2006 Nov;91(11):4287-94. [PubMed] [CrossRef]

  • Iorio R, Sepe A, Giannattasio A, Cirillo F, Spagnuolo MI, Franzese A, Fontana S, Aufiero D, Perna F, Vegnente A, Matarese G. Immune phenotype and serum leptin in children with obesity-related liver disease. J Clin Endocrinol Metab. 2006 Jan;91(1):341-4. [CrossRef] [PubMed]

  • Steinberger J, Steffen L, Jacobs DR Jr, Moran A, Hong CP, Sinaiko AR. Relation of leptin to insulin resistance syndrome in children. Obes Res. 2003 Sep;11(9):1124-30. [CrossRef] [PubMed]

  • Nakamuta M, Tada S, Uchimura K, Enjoji M, Kinukawa N, Iwamoto H, Sugimoto R, Shimada M, Ohashi M, Sugimachi K, Nawata H. Serum leptin levels in patients with nonalcoholic chronic liver disease. Hepatogastroenterology. 2001 Mar-Apr;48(38):527-32. [PubMed]

  • Uygun A, Kadayifci A, Yesilova Z, Erdil A, Yaman H, Saka M, Deveci MS, Bagci S, Gulsen M, Karaeren N, Dagalp K. Serum leptin levels in patients with nonalcoholic steatohepatitis. Am J Gastroenterol. 2000 Dec;95(12):3584-9. [CrossRef] [PubMed]

  • Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002 Sep;123(3):745-50. [CrossRef] [PubMed]

  • Baranova A, Gowder SJ, Schlauch K, Elariny H, Collantes R, Afendy A, Ong JP, Goodman Z, Chandhoke V, Younossi ZM. Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance. Obes Surg. 2006 Sep;16(9):1118-25. [PubMed] [CrossRef]

  • Musso G, Gambino R, Durazzo M, Biroli G, Carello M, Fagà E, Pacini G, De Michieli F, Rabbione L, Premoli A, Cassader M, Pagano G. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology. 2005 Nov;42(5):1175-83. [CrossRef] [PubMed]

  • Vuppalanchi R, Marri S, Kolwankar D, Considine RV, Chalasani N. Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study. J Clin Gastroenterol. 2005 Mar;39(3):237-42. [PubMed] [CrossRef]

  • Venturi C, Zoppini G, Zamboni C, Muggeo M. Insulin sensitivity and hepatic steatosis in obese subjects with normal glucose tolerance. Nutr Metab Cardiovasc Dis. 2004 Aug;14(4):200-4. [PubMed] [CrossRef]

  • Aller R, de Luis DA, Fernandez L, Calle F, Velayos B, Olcoz JL, Izaola O, Sagrado MG, Conde R, Gonzalez JM. Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease. Dig Dis Sci. 2008 Apr;53(4):1088-92. [PubMed] [CrossRef] [Web of Science]

  • Perseghin G, Lattuada G, De Cobelli F, Ntali G, Esposito A, Burska A, Belloni E, Canu T, Ragogna F, Scifo P, Del Maschio A, Luzi L. Serum resistin and hepatic fat content in nondiabetic individuals. J Clin Endocrinol Metab. 2006 Dec;91(12):5122-5. [PubMed] [CrossRef]

  • Gerber M, Boettner A, Seidel B, Lammert A, Bär J, Schuster E, Thiery J, Kiess W, Kratzsch J. Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance. J Clin Endocrinol Metab. 2005 Aug;90(8):4503-9. [PubMed] [CrossRef]

  • Zheng M, Cai WM, Weng HL, Liu RH. ROC curves in evaluation of serum fibrosis indices for hepatic fibrosis. World J Gastroenterol. 2002 Dec;8(6):1073-6. [PubMed]

  • Patel K, Gordon SC, Jacobson I, Hézode C, Oh E, Smith KM, Pawlotsky JM, McHutchison JG. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol. 2004 Dec;41(6):935-42. [PubMed] [CrossRef]

  • Manco M, Marcellini M, Giannone G, Nobili V. Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease. Am J Clin Pathol. 2007 Jun;127(6):954-60. [CrossRef] [PubMed] [Web of Science]

  • Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, Forlani G, Melchionda N. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med. 1999 Nov;107(5):450-5. [CrossRef] [PubMed]

  • Rashid M, Roberts EA. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 2000 Jan;30(1):48-53. [PubMed] [CrossRef]

  • Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr. 2003 Oct;143(4):500-5. [CrossRef] [PubMed]

  • Chan DF, Li AM, Chu WC, Chan MH, Wong EM, Liu EK, Chan IH, Yin J, Lam CW, Fok TF, Nelson EA. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord. 2004 Oct;28(10):1257-63. [PubMed] [CrossRef]

  • Chitturi S, George J. Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis. Curr Gastroenterol Rep. 2003 Feb;5(1):18-25. [PubMed] [CrossRef]

  • Ciba I, Widhalm K. The association between non-alcoholic fatty liver disease and insulin resistance in 20 obese children and adolescents. Acta Paediatr. 2007 Jan;96(1):109-12. [Web of Science] [PubMed] [CrossRef]

  • Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001 Apr;120(5):1183-92. [PubMed] [CrossRef]

Comments (0)

Please log in or register to comment.